CTLA4 and neoplasm: Concurrently, neoplastic cells exploit immune checkpoint signaling, most notably through PD-1/PD-L1 and CTLA-4 axes, to subvert host immune surveillance and establish an immunosuppressive tumor microenvironment [49].